ORPEA SA operates nursing homes, assisted-living facilities, post-acute and rehabilitation hospitals, and psychiatric hospitals.
Price History & Performance
|Historical stock prices|
|Current Share Price||€88.70|
|52 Week High||€83.30|
|52 Week Low||€119.80|
|1 Month Change||-14.71%|
|3 Month Change||-14.67%|
|1 Year Change||-3.42%|
|3 Year Change||-16.28%|
|5 Year Change||14.75%|
|Change since IPO||1,131.94%|
Recent News & Updates
Is Now An Opportune Moment To Examine Orpea SA (EPA:ORP)?
While Orpea SA ( EPA:ORP ) might not be the most widely known stock at the moment, it received a lot of attention from...
Is Orpea (EPA:ORP) Using Too Much Debt?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Orpea (EPA:ORP) Will Be Hoping To Turn Its Returns On Capital Around
If you're looking for a multi-bagger, there's a few things to keep an eye out for. Ideally, a business will show two...
|ORP||FR Healthcare||FR Market|
Return vs Industry: ORP underperformed the French Healthcare industry which returned 6.1% over the past year.
Return vs Market: ORP underperformed the French Market which returned 35.9% over the past year.
Stable Share Price: ORP is less volatile than 75% of French stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: ORP's weekly volatility (3%) has been stable over the past year.
About the Company
|1989||54,424||Yves Le Masne||https://www.orpea-corp.com|
ORPEA SA operates nursing homes, assisted-living facilities, post-acute and rehabilitation hospitals, and psychiatric hospitals. Its nursing home facilities provide personalized support services; and logistical and residential services, including accommodation, meals, and laundry and room cleaning, as well as various daily event, entertainment, and therapeutic workshop services. The company’s post-acute and rehabilitation hospitals offer services for geriatrics, musculoskeletal, nervous system, cardiovascular, hematology, and oncology conditions, as well as patients in a persistent vegetative state or in a minimally conscious state.
Orpea Fundamentals Summary
|ORP fundamental statistics|
Is ORP overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|ORP income statement (TTM)|
|Cost of Revenue||€3.12b|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
|Earnings per share (EPS)||2.93|
|Net Profit Margin||4.63%|
How did ORP perform over the long term?See historical performance and comparison
1.0%Current Dividend Yield
Is Orpea undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: ORP (€88.7) is trading below our estimate of fair value (€162.94)
Significantly Below Fair Value: ORP is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: ORP is good value based on its PE Ratio (30.3x) compared to the French Healthcare industry average (30.9x).
PE vs Market: ORP is poor value based on its PE Ratio (30.3x) compared to the French market (18.9x).
Price to Earnings Growth Ratio
PEG Ratio: ORP is poor value based on its PEG Ratio (1.8x)
Price to Book Ratio
PB vs Industry: ORP is good value based on its PB Ratio (1.6x) compared to the FR Healthcare industry average (2.3x).
How is Orpea forecast to perform in the next 1 to 3 years based on estimates from 12 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ORP's forecast earnings growth (16.8% per year) is above the savings rate (0.3%).
Earnings vs Market: ORP's earnings (16.8% per year) are forecast to grow faster than the French market (12.7% per year).
High Growth Earnings: ORP's earnings are forecast to grow, but not significantly.
Revenue vs Market: ORP's revenue (7.8% per year) is forecast to grow faster than the French market (6.3% per year).
High Growth Revenue: ORP's revenue (7.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ORP's Return on Equity is forecast to be low in 3 years time (7.8%).
How has Orpea performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: ORP has a large one-off gain of €223.4M impacting its June 30 2021 financial results.
Growing Profit Margin: ORP's current net profit margins (4.6%) are lower than last year (5.1%).
Past Earnings Growth Analysis
Earnings Trend: ORP's earnings have declined by 0.6% per year over the past 5 years.
Accelerating Growth: ORP's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: ORP had negative earnings growth (-1.6%) over the past year, making it difficult to compare to the Healthcare industry average (31.2%).
Return on Equity
High ROE: ORP's Return on Equity (5.3%) is considered low.
How is Orpea's financial position?
Financial Position Analysis
Short Term Liabilities: ORP's short term assets (€2.5B) do not cover its short term liabilities (€3.1B).
Long Term Liabilities: ORP's short term assets (€2.5B) do not cover its long term liabilities (€11.1B).
Debt to Equity History and Analysis
Debt Level: ORP's debt to equity ratio (233.1%) is considered high.
Reducing Debt: ORP's debt to equity ratio has increased from 221.9% to 233.1% over the past 5 years.
Debt Coverage: ORP's debt is not well covered by operating cash flow (9.2%).
Interest Coverage: ORP's interest payments on its debt are not well covered by EBIT (1.8x coverage).
What is Orpea current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: ORP's dividend (1.01%) isn’t notable compared to the bottom 25% of dividend payers in the French market (1.33%).
High Dividend: ORP's dividend (1.01%) is low compared to the top 25% of dividend payers in the French market (3.95%).
Stability and Growth of Payments
Stable Dividend: ORP's dividend payments have been volatile in the past 10 years.
Growing Dividend: ORP's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (30.7%), ORP's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: ORP's dividends in 3 years are forecast to be well covered by earnings (37.4% payout ratio).
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Yves Le Masne (59 yo)
Mr. Yves Le Masne has been the Chief Executive Officer of Orpea SA since February 15, 2011 and served as its Chief Financial Officer and Chief Operating Officer since 2006. Previously, Mr. Le Masne served...
CEO Compensation Analysis
Compensation vs Market: Yves's total compensation ($USD2.29M) is about average for companies of similar size in the French market ($USD2.74M).
Compensation vs Earnings: Yves's compensation has been consistent with company performance over the past year.
Experienced Board: ORP's board of directors are considered experienced (4.7 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Orpea SA's employee growth, exchange listings and data sources
- Name: Orpea SA
- Ticker: ORP
- Exchange: ENXTPA
- Founded: 1989
- Industry: Health Care Facilities
- Sector: Healthcare
- Market Cap: €5.729b
- Shares outstanding: 64.59m
- Website: https://www.orpea-corp.com
Number of Employees
- Orpea SA
- 12, rue Jean-Jaurès
- CS 10032
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/10/16 17:58|
|End of Day Share Price||2021/10/15 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.